Refractec’s ViewPoint Gains FDA Approval For Limited Diopter Range

Refractec's eight direct sales reps immediately will begin marketing the ViewPoint CK system, which allows +1.0 to +2.25 diopters of presbyopia correction, as recommended by FDA's Ophthalmic Devices Panel

More from Archive

More from Medtech Insight